Sci. Signal., 10 January 2012
Science Signaling Podcast: 10 January 2012
Travis L. Biechele1,2, Andy J. Chien1,2, Randall T. Moon1, and Annalisa M. VanHook3
1 Department of Pharmacology, Howard Hughes Medical Institute, and the Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington 98109, USA.
Abstract: This Podcast features a conversation with authors of a Research Article published in the 10 January 2012 issue of Science Signaling. Travis Biechele, Andy Chien, and Randy Moon discuss their finding that some melanoma cell lines exhibited increased cell death (apoptosis) when signaling through the kinase BRAF was inhibited simultaneously with activation of the Wnt/β-catenin pathway. Melanoma is an aggressive form of skin cancer that is sometimes associated with an activated mutant version of BRAF (BRAFV600E). Some melanoma patients with this mutation fail to exhibit long-term responsiveness to inhibition of BRAF, so additional therapies are needed to overcome this resistance to apoptosis. The findings reported in this study suggest that inhibiting BRAF concomitantly with stimulating Wnt/β-catenin signaling may be an effective strategy for restoring susceptibility to apoptosis in apoptosis-resistant melanomas.
Citation: T. L. Biechele, A. J. Chien, R. T. Moon, A. M. VanHook, Science Signaling Podcast: 10 January 2012. Sci. Signal. 5, pc1 (2012).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882